Skip to main content

Table 1 Cell-cycle phase distribution (%) of 72 h HS7-treated CL1-0 cells

From: Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells

Treatment

Sub-G1 (%)a

Cell-cycle distribution

G0/G1 (%)

S (%)

G2/M (%)

Control

1.42

69.8

14.6

15.6

HS7 3.125 μg/mL

1.33

65.9

13.2

20.9

HS7 6.25 μg/mL

1.63

68.3

13.6

18.1

HS7 12.5 μg/mL

1.73

68

14.4

17.6

HS7 25 μg/mL

10.06

63.1

18.6

18.3

  1. aSub-G1 proportion is excluded from the percentage calculation of cell-cycle distribution